AVEO Oncology
AVEO
#7063
Rank
โ‚น49.33 B
Marketcap
โ‚น1,419
Share price
0.00%
Change (1 day)
199.49%
Change (1 year)

AVEO Oncology (AVEO) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : โ‚น6.84 Billion

According to AVEO Oncology 's latest financial reports the company's total liabilities are โ‚น6.84 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AVEO Oncology - Total liabilities on balance sheet (from 2008 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31โ‚น4.42 B91.43%
2020-12-31โ‚น2.31 B-9.31%
2019-12-31โ‚น2.54 B-33.9%
2018-12-31โ‚น3.85 B-33.59%
2017-12-31โ‚น5.80 B192.62%
2016-12-31โ‚น1.98 B28.1%
2015-12-31โ‚น1.54 B-51.16%
2014-12-31โ‚น3.17 B-32.79%
2013-12-31โ‚น4.72 B-2.62%
2012-12-31โ‚น4.84 B28.14%
2011-12-31โ‚น3.78 B6.49%
2010-12-31โ‚น3.55 B6.38%
2009-12-31โ‚น3.33 B-58.83%
2008-12-31โ‚น8.11 B24.44%
2007-12-31โ‚น6.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
โ‚น8.131 T 118,622.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.751 T 113,078.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1.058 T 15,348.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น880.08 B 12,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น6.768 T 98,717.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น2.14 B-68.68%๐Ÿ‡บ๐Ÿ‡ธ USA